China Launches ‘Find Medicine’ Feature for Insured Patients
China’s National Healthcare Security Administration (NHSA) launched a new digital service on July 3, 2026, called the “Find Medicine” (医保找药) feature, designed to help the country’s hundreds of millions of insured patients easily locate medications covered by basic medical insurance and commercial insurance innovative drugs. The tool, built on the nationwide unified medical insurance information platform, aims to make drug purchasing more efficient, transparent, and convenient, according to Xinhua News Agency.
How the Feature Works
The “Find Medicine” feature allows users to search for a specific drug and instantly see which designated medical institutions or retail pharmacies have had settlement records for that medication within the past month. The data is updated daily and covers all designated medical institutions and retail pharmacies across China. The system supports both fuzzy search and precise search for drugs listed in the basic medical insurance drug catalog as well as the commercial insurance innovative drug catalog.
According to the NHSA’s official announcement, the feature was developed “to further enhance the convenience of medical insurance services” and to help insured citizens “more conveniently find where they can purchase medical insurance drugs and commercial insurance innovative drugs.”
Patients can access the service through multiple channels, including the NHSA’s WeChat public account, the National Healthcare Security Service Platform App, and mini-programs on both Alipay and WeChat.
Addressing a Common Pain Point
The launch addresses a long-standing challenge for patients: knowing that a drug is covered by insurance but not knowing where to find it. Previously, patients often had to call multiple hospitals and pharmacies or visit them in person to locate specific medications. As The Paper detailed in its operational guide, the new feature streamlines this process into a simple digital search.
The NHSA noted that the feature covers drugs from both the basic medical insurance catalog, which includes over 3,000 medications, and the commercial insurance innovative drug catalog, which includes newer, often more expensive treatments. This dual coverage reflects China’s push toward a multi-tiered medical security system that integrates basic insurance with supplementary commercial insurance.
Important Limitations
The NHSA has issued a clear disclaimer: the settlement records are based on the past month and may not reflect real-time inventory. “Whether an institution currently has the medication should be verified on-site,” the agency stated in its announcement. This means the feature serves as a powerful指引 tool but not a guarantee of current stock.
Broader Significance
The launch represents another milestone in China’s ongoing digital transformation of public services. Over the past decade, the NHSA has built a nationwide unified medical insurance information platform that now serves as the backbone for cross-regional settlement, electronic medical insurance credentials, and this new drug-location feature.
China’s basic medical insurance system covers over 1.3 billion people, with participation rates stabilizing at around 95 percent of the population during the 14th Five-Year Plan period (2021-2025). For this vast population, the “Find Medicine” feature promises to reduce the friction of navigating the healthcare system, particularly for patients with chronic conditions who need to regularly locate specific medications.
The inclusion of commercial insurance innovative drugs in the search function also signals China’s commitment to improving access to cutting-edge treatments. By making these drugs easier to find, the NHSA hopes to boost awareness and uptake of newer therapies that might otherwise remain underutilized.
What’s Next
The NHSA has stated it will continue to optimize the feature based on user feedback, with plans to enrich service scenarios and improve the overall user experience. Outstanding questions remain about how the agency will ensure data accuracy across all regions and institutions, and whether real-time inventory data might be incorporated in future iterations. The feature’s adoption among elderly patients, who may be less familiar with digital tools, will also be a key metric of its success.
As China continues to integrate technology with public health services, the “Find Medicine” feature stands as a practical example of how digital platforms can address everyday challenges for ordinary citizens — making the country’s massive healthcare system feel a little smaller and a lot more accessible.